| Income Statement |
| Operating Expenses | 3.42M |
|
| Research and Development Expense | 2.50M |
| Selling, General and Administrative Expense | 846.00K |
| Operating Income | -3.42M |
| Net Income | -2.96M |
| Net Income Common Stock | -2.96M |
| Net Income Common Stock (USD) | -2.96M |
| Consolidated Income | -2.96M |
| Earnings per Basic Share | -0.02 |
| Earnings per Basic Share (USD) | -0.02 |
| Earnings per Diluted Share | -0.02 |
| Earning Before Interest & Taxes (EBIT) | -2.96M |
| Earning Before Interest & Taxes (USD) | -2.96M |
| Weighted Average Shares | 145.97M |
| Weighted Average Shares Diluted | 145.97M |
| Balance Sheet |
| Cash and Equivalents | 49.54M |
| Cash and Equivalents (USD) | 49.54M |
| Current Assets | 49.98M |
| Property, Plant & Equipment Net | 2.28M |
| Total Assets | 52.32M |
| Current Liabilities | 1.46M |
| Total Liabilities | 1.56M |
| Accumulated Retained Earnings (Deficit) | -473.75M |
| Shareholders Equity | 50.77M |
| Shareholders Equity (USD) | 50.77M |
| Assets Non-Current | 2.35M |
| Liabilities Non-Current | 95.00K |
| Trade and Non-Trade Payables | 328.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 67.00K |
| Net Cash Flow from Financing | -349.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.19M |
| Capital Expenditure | -323.00K |
| Net Cash Flow from Investing | -323.00K |
| Net Cash Flow from Operations | -2.52M |
| Share Based Compensation | 359.00K |